哈莫尼生物科技 HRMY
$33.11 +$0.64 (+1.97%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $33.00 -0.33%
开盘$32.70
昨收$32.47
当日区间$32.27 – $33.38
成交量787.2K
市值$1.94B
市盈率（TTM）11.0
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例108.5%+0.44 个百分点，较上季度
持仓机构数399+9 ，较上季度
内部人近期交易24次买入 / 23次卖出净买入
空头持仓比例9.30% 占流通股回补天数 6.2 · 截至 15 Oct 2026
卖空成交量占比21.4%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$4.08M（9个净流入日，11个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有38.5%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从7.77%升至9.30%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| BlackRock | Mutual Fund | 2026/Q3 | +259,923 | 12.6% |
| Valor Management LLC | VC/PE Fund | 2026/Q3 | +700,883 | 1.4% |
| American Century Investment Management | Mutual Fund | 2026/Q3 | +434,333 | 4.4% |
| FMR | Mutual Fund | 2026/Q3 | +416,460 | 6.1% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +317,078 | 4.1% |
| 683 Capital Management, LLC | Hedge Fund | 2026/Q3 | +294,000 | 0.5% |
| Weiss Asset Management, LLC | Hedge Fund | 2026/Q3 | +275,829 | 0.5% |
| Susquehanna International Group, LLP | Private Company | 2026/Q3 | +233,928 | 0.4% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +225,693 | 1.6% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +216,893 | 1.6% |
| Sphera Funds Management Ltd | Hedge Fund | 2026/Q3 | +176,663 | 0.3% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +166,136 | 4.9% |
| Leap Investments LP | Mutual Fund | 2026/Q3 | +135,230 | 0.4% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +119,929 | 2.5% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +118,000 | 2.1% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 17 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Intent to Sell (Form 144) | -35,852 | $42.74 | – |
| 17 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Derivative Exercise and Sale | -38,452 | $43.05 | 13,115 |
| 16 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Intent to Sell (Form 144) | -800 | $42.21 | – |
| 15 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Intent to Sell (Form 144) | -1,800 | $42.17 | – |
| 7 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Derivative Exercise and Sale | -22,954 | $43.10 | 13,115 |
| 7 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Automatic Disposition | -11,000 | $42.79 | 13,115 |
| 3 Sep 2026 | Kumar Budur | Executive VP and Chief Medical & Scientific Officer | Intent to Sell (Form 144) | -5,500 | $41.86 | – |
| 6 Aug 2026 | Valor Management LLC | Intent to Sell (Form 144) | -700,883 | $37.90 | – | |
| 15 Jul 2026 | Stephen Mollichella | Senior VP, Controller & Interim Principal Financial Officer | Initial Statement of Beneficial | +0 | – | 48,472 |
| 1 Jul 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -25,000 | $36.96 | – |
| 29 Jun 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -50,000 | $36.08 | – |
| 25 Jun 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -45,594 | $35.24 | – |
| 23 Jun 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -4,406 | $35.02 | – |
| 8 Jun 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -27,960 | $33.74 | – |
| 4 Jun 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -2,101 | $33.08 | – |
| 3 Jun 2026 | Sandip Kapadia | Former Chief Financial Officer | Intent to Sell (Form 144) | -7,064 | $33.02 | – |
| 13 May 2026 | R. Graf | Independent Director | Other Derivative Acquisition | +21,872 | $30.76 | 21,872 |
| 13 May 2026 | Gary Sender | Independent Director | Other Derivative Acquisition | +21,872 | $30.76 | 21,872 |
| 13 May 2026 | Linda Szyper | Independent Director | Other Derivative Acquisition | +21,872 | $30.76 | 21,872 |
| 13 May 2026 | Geno Germano | Independent Director | Other Derivative Acquisition | +21,231 | $30.76 | 21,231 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 5,413,347 | 9.3% | 6.2 |
| 30 Sep 2026 | 5,532,301 | 9.5% | 5.0 |
| 15 Sep 2026 | 4,628,716 | 7.9% | 4.3 |
| 31 Aug 2026 | 5,164,996 | 8.9% | 9.1 |
| 14 Aug 2026 | 4,136,259 | 7.1% | 4.8 |
| 31 Jul 2026 | 4,496,943 | 7.8% | 5.1 |
暂无评论——快来第一个聊聊 HRMY。
登录后参与讨论。